Atrys Health, S.A. (ATRY)
BME
Real-time Data
07:00 AM
Day's Range
2.5152 wk Range
2.31Profile - ATRY - Atrys Health, S.A.
Profile
Mic Code
XMAD
Sector
Healthcare
Industry
Biotechnology
Employees
553
Atrys Health, S.A. is a Spain-based biomedical company specializing in precision diagnostic services and oncology treatments. Founded in 2007 and headquartered in Madrid, it operates through segments including Diagnosis, Oncology, and Preventive Medicine, delivering integrated solutions like structural and molecular pathology, genetics, nuclear medicine, telemedicine in radiology, cardiology, ophthalmology, dermatology, and advanced therapies such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy. With over 2,200 professionals across eight countries, including Spain, Portugal, and Latin America, Atrys Health emphasizes a 360-degree approach from prevention to cancer treatment, leveraging technology for telediagnosis and personalized care. The company, formerly Althia Health, pioneered telemedicine and radiotherapy innovations, integrating 14 acquisitions since 2018 for robust growth in laboratory testing, tele-diagnostics, and corporate health plans. Classified in the healthcare sector's biotechnology industry, it supports hospitals, insurers, and businesses with research-driven services.
Profile Details
Type
Common Stock
Ceo
Ms. Isabel Lozano Fernandez
Address
PrÃncipe de Vergara 132
City
Madrid
State
MI
Zip
28002
Country
Spain
Phone
34 917 819 465
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
